AR

Alexander Joseph Reif

Merck: 3 patents #3,073 of 9,382Top 35%
GL Glaxosmithkline: 2 patents #156 of 646Top 25%
GL Glaxosmithkline Intellectual Property Development Limited: 2 patents #160 of 550Top 30%
CL Cancer Research Technology Limited: 1 patents #278 of 493Top 60%
📍 Collegeville, PA: #132 of 630 inventorsTop 25%
🗺 Pennsylvania: #11,794 of 74,527 inventorsTop 20%
Overall (All Time): #677,777 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
12247033 Triazole-substituted imidazo[1,2-a]pyrimidines as cGAS inhibitors Adam Kenneth Charnley, Janos Botyanszki, Xiaoyang Dong, Philip G. Humphreys, Bryan Wayne King +7 more 2025-03-11
10975056 Substituted pyridines as inhibitors of DNMT1 Nicholas D. Adams, Andrew B. Benowitz, María Lourdes Rueda Benede, Karen Anderson Evans, David T. FOSBENNER +12 more 2021-04-13
9340529 Triazolones as fatty acid synthase inhibitors Nicholas D. Adams, Christopher Joseph Aquino, Amita M. Chaudhari, Jonathan M. Ghergurovich, Terence John Kiesow +2 more 2016-05-17
9315518 Imidazopyridin-2-one derivatives Hannah Fiji, Michael J. Kelly, III, Jeffrey Kern, Mark E. Layton, Joseph E. Pero +1 more 2016-04-19
8993779 Positive allosteric modulators of MGLUR2 Vadim Dudkin, Mark E. Fraley, Kenneth L. Arrington, Mark E. Layton, Kevin J. Rodzinak +1 more 2015-03-31
8802864 Triazolones as fatty acid synthase inhibitors Nicholas D. Adams, Christopher Joseph Aquino, Amita M. Chaudhari, Jonathan M. Ghergurovich, Terence John Kiesow +2 more 2014-08-12
8765784 Positive allosteric modulators of MGLUR2 Kenneth L. Arrington, Vadim Dudkin, Mark E. Layton, Joseph E. Pero 2014-07-01